针对晚期肺腺癌的局部治疗与抗PD-1免疫疗法相结合:一个病例报告
Na Wu1, Xiaoxin Yang2, Yan Zhai1
1Interventional Diagnostic and Therapeutic Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
Journal of cancer research and therapeutics
|April 30, 2024
概括
局部治疗与编程细胞死亡蛋白1 (PD-1) 抑制剂相结合,在患有晚期肺腺癌 (LUAD) 的患者中实现了持久的完整反应. 这种组合为治疗转移性LUAD提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 是一种主要的肺癌形式.
- 目前的治疗方法,如PD-1抑制剂,对LUAD的疗效有限.
- 将免疫疗法与局部治疗结合起来是一个有希望的策略.
研究的目的:
- 介绍一篇关于LUAD治疗的案例研究.
- 为了评估局部治疗与PD-1抑制剂结合的疗效.
主要方法:
- 一名患有多次LUAD转移的患者接受了局部治疗.
- 患者同时接受了PD-1抑制剂的治疗.
主要成果:
- 患者实现了完全的反应.
- 完整的反应已经持续了超过3年.
结论:
- 局部治疗与PD-1 抑制剂相结合,可以在高级的LUAD中带来持久的完整反应.
- 这种多式联络方法需要对LUAD治疗进行进一步的研究.
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


